Karim Chamie

Title(s)Associate Professor-in-Residence, Urology
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Quality of care in patients with bladder cancer.
    NIH F32CA144461Jan 25, 2010 - Jan 24, 2012
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement. Prostate Cancer Prostatic Dis. 2023 Aug 08. Javier-DesLoges J, Dall'Era MA, Brisbane W, Chamie K, Washington SL, Chandrasekar T, Marks LS, Nguyen H, Daneshvar M, Gin G, Kane CJ, Bagrodia A, Cooperberg MR. PMID: 37553435.
      View in: PubMed   Mentions:    Fields:    
    2. A SEER-Medicare Based Quality Score for Patients With Metastatic Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2023 Jun 22. Joyce DD, Shan Y, Stewart CA, Chamie K, Galsky MD, Boorjian SA, Williams SB, Sharma V. PMID: 37537088.
      View in: PubMed   Mentions:    Fields:    
    3. Contemporary Systemic Therapies in Urothelial Carcinoma. Urology. 2023 04; 174:150-158. Zhang JH, Starr SL, Chamie K. PMID: 36682700.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Readmissions after radical nephrectomy in a national cohort. Scand J Urol. 2023 Feb-Dec; 57(1-6):75-80. Michel J, Jivanji D, Goel AN, Lec PM, Lenis AT, Litwin MS, Chamie K. PMID: 36644811.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort. Urology. 2023 03; 173:134-141. Sharma V, Chamie K, Schoenberg M, Lee VS, Fero K, Lec P, Munneke JR, Aaronson DS, Kushi LH, Quesenberry CP, Tang L, Kwan ML. PMID: 36574911.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant Candidates. Urology. 2023 03; 173:127-133. Muraki P, Lee C, Patel N, Arevalo A, Ohtake S, Mendhiratta N, Chamie K, Agopian V, Benharash P, Shuch B. PMID: 36403677.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancer. Cancer Med. 2023 03; 12(5):6437-6444. Patel N, Hakansson A, Ohtake S, Muraki P, Proudfout JA, Liu Y, Webber L, Ibarra A, Liu VYT, Davicioni E, Chamie K, Pantuck A, Shuch B. PMID: 36397716; PMCID: PMC10028022.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    8. Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):142-152. Ma TM, Ballas LK, Wilhalme H, Sachdeva A, Chong N, Sharma S, Yang T, Basehart V, Reiter RE, Saigal C, Chamie K, Litwin MS, Rettig MB, Nickols NG, Yoon SM, Smith L, Gao Y, Steinberg ML, Cao M, Kishan AU. PMID: 36007724.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    9. Comparing costs of renal preservation versus radical nephroureterectomy management among patients with non-metastatic upper tract urothelial carcinoma. Urol Oncol. 2022 07; 40(7):345.e1-345.e7. Williams SB, Shan Y, Fero KE, Movva G, Baillargeon J, Tyler DS, Chamie K. PMID: 35351369.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013. JAMA Netw Open. 2022 03 01; 5(3):e223050. Bree KK, Shan Y, Hensley PJ, Lobo N, Hu C, Tyler DS, Chamie K, Kamat AM, Williams SB. PMID: 35302627; PMCID: PMC8933744.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    11. Reply by Authors. J Urol. 2022 04; 207(4):788. Matin SF, Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, Lerner SP. PMID: 34985341.
      View in: PubMed   Mentions:    Fields:    
    12. Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report. J Urol. 2022 Apr; 207(4):779-788. Matin SF, Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, Lerner SP. PMID: 34915741.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    13. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis. JAMA Netw Open. 2021 12 01; 4(12):e2139769. Ma TM, Romero T, Nickols NG, Rettig MB, Garraway IP, Roach M, Michalski JM, Pisansky TM, Lee WR, Jones CU, Rosenthal SA, Wang C, Hartman H, Nguyen PL, Feng FY, Boutros PC, Saigal C, Chamie K, Jackson WC, Morgan TM, Mehra R, Salami SS, Vince R, Schaeffer EM, Mahal BA, Dess RT, Steinberg ML, Elashoff D, Sandler HM, Spratt DE, Kishan AU. PMID: 34964855; PMCID: PMC8717118.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer. Clin Genitourin Cancer. 2022 04; 20(2):e94-e103. Xiang M, Chang AJ, Chamie K, Drakaki A, Pollom EL, Steinberg ML, Kishan AU. PMID: 34866018.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. AUTHOR REPLY. Urology. 2021 11; 157:196. Fero KE, Litwin MS, Leapman M, Chamie K. PMID: 34895591.
      View in: PubMed   Mentions:    Fields:    
    16. Treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma. JNCI Cancer Spectr. 2021 12; 5(6). Fero KE, Shan Y, Lec PM, Sharma V, Srinivasan A, Movva G, Baillargeon J, Chamie K, Williams SB. PMID: 34805743; PMCID: PMC8599752.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial. J Urol. 2022 01; 207(1):61-69. Chevli KK, Shore ND, Trainer A, Smith AB, Saltzstein D, Ehrlich Y, Raman JD, Friedman B, D'Anna R, Morris D, Hu B, Tyson M, Sankin A, Kates M, Linehan J, Scherr D, Kester S, Verni M, Chamie K, Karsh L, Cinman A, Meads A, Lahiri S, Malinowski M, Gabai N, Raju S, Schoenberg M, Seltzer E, Huang WC. PMID: 34433303; PMCID: PMC8667793.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    18. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein. Urology. 2021 11; 157:188-196. Fero KE, Lec PM, Sharma V, Lenis AT, Low J, Litwin MS, Leapman MS, Chamie K. PMID: 34389428.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-analysis. Reply. J Urol. 2021 10; 206(4):1072. Sharma V, Miest TS, Chamie K, Matin SF, Boorjian SA, Potretzke AM. PMID: 34228501.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Reply by Authors. J Urol. 2021 09; 206(3):567. Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. PMID: 34121427.
      View in: PubMed   Mentions:    Fields:    
    21. Risk factors for penile fracture compared with a surgical control cohort in the United States: the role of substance abuse. Asian J Androl. 2021 May-Jun; 23(3):236-239. Christian-Miller N, Lenis AT, Fero KE, Madrigral J, Eleswarapu SV, Chamie K, Benharash P. PMID: 33243961; PMCID: PMC8152430.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. J Urol. 2021 Sep; 206(3):558-567. Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. PMID: 33908802.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    23. The role of neoadjuvant chemotherapy, lymph node dissection, and treatment delay in patients with muscle-invasive bladder cancer undergoing partial cystectomy. Urol Oncol. 2021 08; 39(8):496.e17-496.e24. Lenis AT, Fero KE, Ojeaburu L, Lec PM, Golla V, Brisbane W, Leapman MS, Chamie K. PMID: 33640225.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma In Situ of the Bladder. J Urol. 2021 May; 205(5):1326-1335. Wymer KM, Sharma V, Saigal CS, Chamie K, Litwin MS, Packiam VT, Mossanen M, Pagliaro LC, Borah BJ, Boorjian SA. PMID: 33347775.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Urinary Diversion. JAMA. 2020 12 01; 324(21):2222. Lenis AT, Lec PM, Chamie K. PMID: 33258891.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Bladder Cancer. JAMA. 2020 11 17; 324(19):2006. Lenis AT, Lec PM, Chamie K. PMID: 33201205.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    27. Bladder Cancer: A Review. JAMA. 2020 Nov 17; 324(19):1980-1991. Lenis AT, Lec PM, Chamie K, Mshs MD. PMID: 33201207.
      View in: PubMed   Mentions: 447     Fields:    Translation:Humans
    28. A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma. J Immunother. 2020 Nov/Dec; 43(9):273-282. Faiena I, Comin-Anduix B, Berent-Maoz B, Bot A, Zomorodian N, Sachdeva A, Said J, Cheung-Lau G, Pang J, Macabali M, Chodon T, Wang X, Cabrera P, Kaplan-Lefko P, Chamie K, Belldegrun AS, Pantuck AJ, Drakaki A. PMID: 32925563.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    29. Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study. Urol Oncol. 2021 03; 39(3):194.e17-194.e24. Lec PM, Venkataramana A, Lenis AT, Fero KE, Sharma V, Golla V, Gollapudi K, Blumberg J, Chamie K. PMID: 33012575.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review. J Gastrointest Surg. 2021 01; 25(1):293-302. Chamie K, Golla V, Lenis AT, Lec PM, Rahman S, Viscusi ER. PMID: 32779081; PMCID: PMC7851096.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. "Real-world" outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma. Urol Oncol. 2021 01; 39(1):76.e15-76.e22. Drakaki A, Pantuck A, Mhatre SK, Dhillon PK, Davarpanah N, Degaonkar V, Surinach A, Chamie K, Grivas P. PMID: 32778476.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Analysis of guideline recommended use of renal mass biopsy and association with treatment. Can J Urol. 2020 08; 27(4):10285-10293. Michel J, Lenis AT, Lec PM, Golla V, Johnson DC, Gollapudi K, Blumberg J, Shuch BM, Chamie K. PMID: 32861253.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Impact of Diagnosing Urologists and Hospitals on the Use of Radical Cystectomy. Eur Urol Open Sci. 2020 Jul; 19:27-36. Golla V, Shan Y, Mehta HB, Klaassen Z, Tyler DS, Baillargeon J, Kamat AM, Freedland SJ, Gore JL, Chamie K, Kuo YF, Williams SB. PMID: 34337452; PMCID: PMC8317809.
      View in: PubMed   Mentions: 1  
    34. The Role of Opioids and Their Receptors in Urological Malignancy: A Review. J Urol. 2020 Dec; 204(6):1150-1159. Lec PM, Lenis AT, Golla V, Brisbane W, Shuch B, Garraway IP, Reiter RE, Chamie K. PMID: 32516030.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    35. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival. Urol Oncol. 2020 10; 38(10):796.e7-796.e14. Lenis AT, Lec PM, Michel J, Brisbane W, Golla V, Sharma V, Gollapudi K, Blumberg J, Chamie K. PMID: 32446641.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study. Urol Oncol. 2020 11; 38(11):854.e1-854.e9. Lec PM, Lenis AT, Brisbane W, Sharma V, Golla V, Gollapudi K, Blumberg J, Drakaki A, Bergman J, Chamie K. PMID: 32430252.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Sodium Fluorescein for Identification of Intraoperative Urine Leaks During Partial Nephrectomy. Urology. 2020 08; 142:249. Kunitsky K, Lec PM, Brisbane W, Lenis AT, Chamie K. PMID: 32387291.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Lancet Oncol. 2020 06; 21(6):776-785. Kleinmann N, Matin SF, Pierorazio PM, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky S, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Stern J, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Adibi M, Amin MB, Seltzer E, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Schoenberg M, Lerner SP. PMID: 32631491.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    39. The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy. World J Urol. 2020 Dec; 38(12):3113-3119. Lenis AT, Golla V, Lec PM, Johnson DC, Faiena I, Lee C, Rahman S, Chamie K. PMID: 32072229.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors. Urol Oncol. 2020 01; 38(1):1.e17-1.e23. Pooli A, Salmasi A, Johnson DC, Lenis AT, Faiena I, Lebacle C, Golla V, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 31537483.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Predicting Short-term Outcomes After Radical Cystectomy Based on Frailty. Urology. 2019 11; 133:25-33. Michel J, Goel AN, Golla V, Lenis AT, Johnson DC, Chamie K, Litwin MS. PMID: 31306670.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    42. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival. Urol Oncol. 2019 09; 37(9):577.e9-577.e16. Lenis AT, Burton CS, Golla V, Pooli A, Faiena I, Johnson DC, Salmasi A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30930099; PMCID: PMC6698401.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    43. Second primary lung cancer in United States Cancer Survivors, 1992-2008. Cancer Causes Control. 2019 May; 30(5):465-475. Donin NM, Kwan L, Lenis AT, Drakaki A, Chamie K. PMID: 30900065.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    44. Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma. Cancer Immunol Immunother. 2019 May; 68(5):743-751. Faiena I, Astrow SH, Elashoff DA, Jain R, Bot A, Chamie K, Belldegrun AS, Pantuck AJ, Drakaki A. PMID: 30790015.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. Eur Urol Oncol. 2021 04; 4(2):327-330. Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU. PMID: 31411981.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer. World J Urol. 2019 Jan; 37(1):61-83. Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ, Sankin AI, Schoenberg MP, Shipley WU, Villers A, Efstathiou JA, Bellmunt J, Stenzl A. PMID: 30684034.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    47. Intravesical Therapy for Non-muscle Invasive Bladder Cancer-Current and Future Options in the Age of Bacillus Calmette-Guerin Shortage. Rev Urol. 2019; 21(4):145-153. Golla V, Lenis AT, Faiena I, Chamie K. PMID: 32071562; PMCID: PMC7020281.
      View in: PubMed   Mentions: 8  
    48. Urinary Cytokine Profile to Predict Response to Intravesical BCG with or without HS-410 Therapy in Patients with Non-muscle-invasive Bladder Cancer. Cancer Epidemiol Biomarkers Prev. 2019 06; 28(6):1036-1044. Salmasi A, Elashoff DA, Guo R, Upfill-Brown A, Rosser CJ, Rose JM, Giffin LC, Gonzalez LE, Chamie K. PMID: 30593457.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    49. Diagnostic biomarkers in non-muscle invasive bladder cancer. World J Urol. 2019 Oct; 37(10):2009-2016. Faiena I, Rosser CJ, Chamie K, Furuya H. PMID: 30467596.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    50. Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better? Urol Oncol. 2019 01; 37(1):63-70. Pooli A, Salmasi A, Faiena I, Lenis AT, Johnson DC, Lebacle C, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30446452.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C. BMC Urol. 2018 Oct 24; 18(1):93. Lenis AT, Asanad K, Blaibel M, Donin NM, Chamie K. PMID: 30355350; PMCID: PMC6201555.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines. World J Urol. 2019 Jun; 37(6):1157-1164. Upfill-Brown A, Lenis AT, Faiena I, Salmasi AH, Johnson DC, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30267197; PMCID: PMC6438772.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    53. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma. Urol Oncol. 2018 12; 36(12):527.e13-527.e19. Salmasi A, Faiena I, Lenis AT, Pooli A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30228094.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer. Eur Urol Oncol. 2019 09; 2(5):497-504. Huo J, Ray-Zack MD, Shan Y, Chamie K, Boorjian SA, Kerr P, Jana B, Freedland SJ, Kamat AM, Mehta HB, Williams SB. PMID: 31411998; PMCID: PMC8362849.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    55. Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer. Eur Urol Oncol. 2019 03; 2(2):119-125. Williams SB, Hudgins HK, Ray-Zack MD, Chamie K, Smaldone MC, Boorjian SA, Daneshmand S, Black PC, Kamat AM, Goebell PJ, Seiler R, Schmitz-Drager B, Nawroth R, Baillargeon J, Klaassen Z, Kulkarni GS, Kim SP, Lee EK, Holzbeierlein JM, Hollenbeck BK, Gore JL. PMID: 31017086; PMCID: PMC10039463.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    56. Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center. Urol Oncol. 2018 09; 36(9):401.e19-401.e25. Salmasi A, Faiena I, Wu J, Sisk AE, Sachveda A, Vandel JJ, Chamie K, Marks LS, Reiter RE. PMID: 30064933.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. Eur Urol Oncol. 2018 Jun; 1(2):91-100. Williams SB, Kamat AM, Chamie K, Froehner M, Wirth MP, Wiklund PN, Black PC, Steinberg GD, Boorjian SA, Daneshmand S, Goebell PJ, Pohar KS, Shariat SF, Thalmann GN. PMID: 30345422; PMCID: PMC6190914.
      View in: PubMed   Mentions: 10     Fields:    
    58. Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy. World J Urol. 2018 Nov; 36(11):1825-1833. Faiena I, Salmasi A, Mendhiratta N, Lenis AT, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 29752514.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. Drug Des Devel Ther. 2018; 12:209-215. Faiena I, Cummings AL, Crosetti AM, Pantuck AJ, Chamie K, Drakaki A. PMID: 29416316; PMCID: PMC5789049.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    60. Trends in urinary diversion after radical cystectomy for urothelial carcinoma. World J Urol. 2018 Mar; 36(3):409-416. Bachour K, Faiena I, Salmasi A, Lenis AT, Johnson DC, Pooli A, Drakaki A, Pantuck AJ, Chamie K. PMID: 29299664.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    61. Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma. Urol Oncol. 2018 02; 36(2):78.e21-78.e28. Lenis AT, Salmasi AH, Donin NM, Faiena I, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun AS, Pantuck AJ, Chamie K. PMID: 29128421.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    62. The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era. Clin Genitourin Cancer. 2018 04; 16(2):e269-e276. Liu ST, Hui G, Mathis C, Chamie K, Pantuck AJ, Drakaki A. PMID: 29199023.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    63. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection. Urol Oncol. 2018 02; 36(2):79.e19-79.e26. Faiena I, Salmasi A, Lenis AT, Donin NM, Johnson DC, Bachour K, Drakaki A, Belldegrun AS, Pantuck AJ, Chamie K. PMID: 29103965.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    64. Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma. Urol Oncol. 2018 01; 36(1):9.e1-9.e9. Lenis AT, Donin NM, Faiena I, Salmasi A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun A, Pantuck A, Chamie K. PMID: 29066013.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    65. Trends in Aging-Related Services During Nephrectomy: Implications for Surgery in an Aging Population. J Am Geriatr Soc. 2017 Oct; 65(10):2290-2296. Tan HJ, Litwin MS, Chamie K, Saliba D, Hu JC. PMID: 28801975; PMCID: PMC5641234.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. Urol Oncol. 2018 10; 36(10):440-447. Packiam VT, Lamm DL, Barocas DA, Trainer A, Fand B, Davis RL, Clark W, Kroeger M, Dumbadze I, Chamie K, Kader AK, Curran D, Gutheil J, Kuan A, Yeung AW, Steinberg GD. PMID: 28755959.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCellsCTClinical Trials
    67. Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer. Clin Genitourin Cancer. 2017 Jul 26. Huo J, Chu Y, Chamie K, Smaldone MC, Boorjian SA, Baillargeon JG, Kuo YF, Kerr P, O'Malley P, Orihuela E, Tyler DS, Freedland SJ, Giordano SH, Vikram R, Kamat AM, Williams SB. PMID: 28826932; PMCID: PMC5878135.
      View in: PubMed   Mentions: 6     Fields:    
    68. Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial. JAMA Oncol. 2017 Jul 01; 3(7):913-920. Chamie K, Donin NM, Klöpfer P, Bevan P, Fall B, Wilhelm O, Störkel S, Said J, Gambla M, Hawkins RE, Jankilevich G, Kapoor A, Kopyltsov E, Staehler M, Taari K, Wainstein AJA, Pantuck AJ, Belldegrun AS. PMID: 27787547; PMCID: PMC5824229.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    69. Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer. Cancer Causes Control. 2017 Jul; 28(7):755-766. Williams SB, Huo J, Kosarek CD, Chamie K, Rogers SO, Williams MA, Giordano SH, Kim SP, Kamat AM. PMID: 28477210; PMCID: PMC5497706.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    70. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials. J Urol. 2018 01; 199(1):43-52. Lenis AT, Donin NM, Johnson DC, Faiena I, Salmasi A, Drakaki A, Belldegrun A, Pantuck A, Chamie K. PMID: 28479237; PMCID: PMC5720927.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    71. Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guérin Treatment. Urol Pract. 2018 Mar; 5(2):132-138. Lenis AT, Asanad K, Blaibel M, Donin NM, Chamie K. PMID: 29577063; PMCID: PMC5861375.
      View in: PubMed   Mentions: 7  
    72. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer. 2017 05 01; 123(9):1617-1624. Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez LA, Kim SP, Hoffman KE, Giordano SH, Chapin BF. PMID: 28099688; PMCID: PMC5897905.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    73. Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility. Urol Oncol. 2017 05; 35(5):272-278. Donin NM, Strauss-Ayali D, Agmon-Gerstein Y, Malchi N, Lenis AT, Holden S, Pantuck AJ, Belldegrun AS, Chamie K. PMID: 28065395.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    74. Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer. Cancer Med. 2017 01; 6(1):163-172. Miller ET, Chamie K, Kwan L, Lewis MS, Knudsen BS, Garraway IP. PMID: 27997745; PMCID: PMC5269571.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    75. Patient Function and the Value of Surgical Care for Kidney Cancer. J Urol. 2017 05; 197(5):1200-1207. Tan HJ, Shirk JD, Chamie K, Litwin MS, Hu JC. PMID: 27986531; PMCID: PMC7433987.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    76. Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice. Mol Cancer Ther. 2017 02; 16(2):376-387. Zimmermann M, Wang SS, Zhang H, Lin TY, Malfatti M, Haack K, Ognibene T, Yang H, Airhart S, Turteltaub KW, Cimino GD, Tepper CG, Drakaki A, Chamie K, de Vere White R, Pan CX, Henderson PT. PMID: 27903751; PMCID: PMC5335870.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    77. Regionalization of Cystectomy: Importance of Care Coordination, Bundled Payments and Surgical Ownership. J Urol. 2017 02; 197(2):278-279. Lenis AT, Chamie K. PMID: 27845149.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    78. Development and Validation of an Automated Method to Identify Patients Undergoing Radical Cystectomy for Bladder Cancer Using Natural Language Processing. Urol Pract. 2017 Sep; 4(5):365-372. Tan HJ, Clarke R, Chamie K, Kaplan AL, Chin AI, Litwin MS, Saigal CS, Hackbarth AS. PMID: 37592698.
      View in: PubMed   Mentions:
    79. A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer. Urol Oncol. 2017 02; 35(2):39.e1-39.e7. Donin NM, Chamie K, Lenis AT, Pantuck AJ, Reddy M, Kivlin D, Holldack J, Pozzi R, Hakim G, Karsh LI, Lamm DL, Belkoff LH, Belldegrun AS, Holden S, Shore N. PMID: 28341495.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    80. The Impact of Partnership Status and Social Support on Health Related Quality of Life Outcomes in Men with Prostate Cancer. Urol Pract. 2017 May; 4(3):225-231. Baskin A, Kwan L, Zavala M, Chamie K. PMID: 37592675.
      View in: PubMed   Mentions:
    81. Sustained-release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical Study. Urology. 2017 Jan; 99:270-277. Donin NM, Duarte S, Lenis AT, Caliliw R, Torres C, Smithson A, Strauss-Ayali D, Agmon-Gerstein Y, Malchi N, Said J, Raman SS, Holden S, Pantuck A, Belldegrun AS, Chamie K. PMID: 27720772.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    82. Risk of hospitalisation after primary treatment for prostate cancer. BJU Int. 2017 07; 120(1):48-55. Williams SB, Duan Z, Chamie K, Hoffman KE, Smith BD, Hu JC, Shah JB, Davis JW, Giordano SH. PMID: 27561186; PMCID: PMC6089382.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    83. Racial Disparities in Active Surveillance for Prostate Cancer. J Urol. 2017 02; 197(2):342-349. Krishna S, Fan Y, Jarosek S, Adejoro O, Chamie K, Konety B. PMID: 27596691.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    84. Patient function, long-term survival, and use of surgery in patients with kidney cancer. Cancer. 2016 Dec 15; 122(24):3776-3784. Tan HJ, Chamie K, Daskivich TJ, Litwin MS, Hu JC. PMID: 27518165; PMCID: PMC6156784.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    85. Immunotherapy for the Treatment of Urothelial Carcinoma. J Urol. 2017 01; 197(1):14-22. Donin NM, Lenis AT, Holden S, Drakaki A, Pantuck A, Belldegrun A, Chamie K. PMID: 27460757.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    86. Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 2016 09; 25(9):1326-32. Donin NM, Pantuck A, Klöpfer P, Bevan P, Fall B, Said J, Belldegrun AS, Chamie K. PMID: 27418270.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    87. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. 2016 10; 122(19):3075-86. Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L, Litwin M, Chamie K. PMID: 27377470; PMCID: PMC6192520.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    88. Determinants of radical cystectomy operative time. Urol Oncol. 2016 10; 34(10):431.e17-24. Filson CP, Tan HJ, Chamie K, Laviana AA, Hu JC. PMID: 27372282.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    89. Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non-Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2017 02; 15(1):e25-e31. Lenis AT, Donin NM, Litwin MS, Saigal CS, Lai J, Hanley JM, Konety BR, Chamie K, Urologic Diseases in America Project. PMID: 27432529; PMCID: PMC5183565.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    90. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer. Eur Urol Focus. 2017 04; 3(2-3):258-264. Williams SB, Huo J, Chamie K, Hu JC, Giordano SH, Hoffman KE, Dinney CPN, Kamat AM, Shih YT. PMID: 28753760.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    91. Population-based assessment of determining predictors for quality of prostate cancer surveillance. Cancer. 2015 Dec 01; 121(23):4150-7. Chamie K, Williams SB, Hershman DL, Wright JD, Nguyen PL, Hu JC. PMID: 26307939.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    92. Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer-Reply. JAMA Oncol. 2015 Aug; 1(5):689-90. Williams SB, Chamie K, Hu JC. PMID: 26181144.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Population-Based Assessment of Determining Treatments for Prostate Cancer. JAMA Oncol. 2015 Apr; 1(1):60-7. Chamie K, Williams SB, Hu JC. PMID: 26182305.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    94. Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial. Urol Oncol. 2015 May; 33(5):204.e25-33. Chamie K, Klöpfer P, Bevan P, Störkel S, Said J, Fall B, Belldegrun AS, Pantuck AJ. PMID: 25823535.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    95. Bladder cancer in 2014: From the genomic frontier to immunotherapeutics. Nat Rev Urol. 2015 Feb; 12(2):74-6. Lenis AT, Chamie K. PMID: 25558841.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    96. Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer. Urol Oncol. 2015 Jan; 33(1):20.e9-20.e17. Chamie K, Ballon-Landa E, Daskivich TJ, Bassett JC, Lai J, Hanley JM, Konety BR, Litwin MS, Saigal CS, Urologic Diseases in America Project. PMID: 25443267; PMCID: PMC4274185.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    97. Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link. Cancer. 2015 Feb 01; 121(3):379-85. Chamie K, Ballon-Landa E, Bassett JC, Daskivich TJ, Leventhal M, Deapen D, Litwin MS. PMID: 25339141; PMCID: PMC6209593.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    98. Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC). Healthc (Amst). 2015 Mar; 3(1):43-8. Kaplan AL, Agarwal N, Setlur NP, Tan HJ, Niedzwiecki D, McLaughlin N, Burke MA, Steinberg K, Chamie K, Saigal CS. PMID: 26179588.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    99. Population-based assessment of prostate-specific antigen testing for prostate cancer in the elderly. Urol Oncol. 2015 Feb; 33(2):69.e29-34. Hu JC, Williams SB, Carter SC, Eggener SE, Prasad S, Chamie K, Trinh QD, Sun M, Nguyen PL, Lipsitz SR. PMID: 25017694.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    100. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol. 2014 Oct; 66(4):666-72. Hu JC, Gandaglia G, Karakiewicz PI, Nguyen PL, Trinh QD, Shih YC, Abdollah F, Chamie K, Wright JL, Ganz PA, Sun M. PMID: 24602934.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    101. The role of magnetic resonance imaging in delineating clinically significant prostate cancer. Urology. 2014 Feb; 83(2):369-75. Chamie K, Sonn GA, Finley DS, Tan N, Margolis DJ, Raman SS, Natarajan S, Huang J, Reiter RE. PMID: 24468511; PMCID: PMC3922632.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    102. Building a medical neighborhood in the safety net: an innovative technology improves hematuria workups. Urology. 2013 Dec; 82(6):1277-82. Bergman J, Neuhausen K, Chamie K, Scales CD, Carter S, Kwan L, Lerman SE, Aronson W, Litwin MS. PMID: 24103564.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    103. The future of bladder cancer care in the USA. Nat Rev Urol. 2014 Jan; 11(1):59-62. Kaplan AL, Litwin MS, Chamie K. PMID: 23979659.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    104. Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer. Cancer. 2013 Oct 01; 119(19):3446-53. Daskivich TJ, Chamie K, Kwan L, Dash A, Greenfield S, Litwin MS. PMID: 23861016.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    105. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer. 2013 Sep 01; 119(17):3219-27. Chamie K, Litwin MS, Bassett JC, Daskivich TJ, Lai J, Hanley JM, Konety BR, Saigal CS, Urologic Diseases in America Project. PMID: 23737352; PMCID: PMC3773281.
      View in: PubMed   Mentions: 143     Fields:    Translation:Humans
    106. Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy? Urology. 2013 May; 81(5):949-55. Chamie K, Oberfoell S, Kwan L, Labo J, Wei JT, Litwin MS. PMID: 23477756; PMCID: PMC3634906.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    107. Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma. Cancer. 2013 Apr 15; 119(8):1547-54. Kroeger N, Klatte T, Chamie K, Rao PN, Birkhäuser FD, Sonn GA, Riss J, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 23335244.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    108. Editorial comment. J Urol. 2013 Jan; 189(1):65. Chamie K. PMID: 23164378.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    109. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol. 2012 Aug; 188(2):391-7. Keegan KA, Schupp CW, Chamie K, Hellenthal NJ, Evans CP, Koppie TM. PMID: 22698625; PMCID: PMC3714400.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    110. Impact of a bladder cancer diagnosis on smoking behavior. J Clin Oncol. 2012 May 20; 30(15):1871-8. Bassett JC, Gore JL, Chi AC, Kwan L, McCarthy W, Chamie K, Saigal CS. PMID: 22529264.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    111. Systemic therapy for metastatic renal cell carcinoma: a review and update. Rev Urol. 2012; 14(3-4):65-78. Logan JE, Rampersaud EN, Sonn GA, Chamie K, Belldegrun AS, Pantuck AJ, Slamon DJ, Kabbinavar FF. PMID: 23526579; PMCID: PMC3602729.
      View in: PubMed   Mentions: 15  
    112. Quality of bladder cancer care in the USA. Expert Rev Pharmacoecon Outcomes Res. 2011 Dec; 11(6):619-21. Chamie K, Litwin MS. PMID: 22098276.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    113. Prostate cancer survivorship: lessons from caring for the uninsured. Urol Oncol. 2012 Jan-Feb; 30(1):102-8. Chamie K, Connor SE, Maliski SL, Fink A, Kwan L, Litwin MS. PMID: 22127017; PMCID: PMC3259185.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    114. The role of self-efficacy in quality of life for disadvantaged men with prostate cancer. J Urol. 2011 Nov; 186(5):1855-61. Heckman JE, Chamie K, Maliski SL, Fink A, Kwan L, Connor SE, Litwin MS. PMID: 21944084.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    115. Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol. 2011 Nov; 186(5):1868-73. Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS. PMID: 21944092.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    116. Urolithiasis risk factors in the bariatric population undergoing gastric bypass surgery. Surg Obes Relat Dis. 2013 Jan-Feb; 9(1):83-7. Wu JN, Craig J, Chamie K, Asplin J, Ali MR, Low RK. PMID: 22100051.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    117. Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Intern Med. 2012 May; 27(5):492-9. Chamie K, Daskivich TJ, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS. PMID: 21935751; PMCID: PMC3326114.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    118. The impact of social networks and partnership status on treatment choice in men with localized prostate cancer. BJU Int. 2012 Apr; 109(7):1006-12. Chamie K, Kwan L, Connor SE, Zavala M, Labo J, Litwin MS. PMID: 21895934.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    119. Quality of care in patients with bladder cancer: a case report? Cancer. 2012 Mar 01; 118(5):1412-21. Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS, Urologic Diseases in America Project. PMID: 21823107; PMCID: PMC3213323.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    120. Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer. 2011 Dec 01; 117(23):5392-401. Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS, Urologic Diseases in America Project. PMID: 21780079; PMCID: PMC3206145.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    121. Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes. Urology. 2011 Jul; 78(1):87-92. Yap SA, Schupp CW, Chamie K, Evans CP, Koppie TM. PMID: 21601253.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    122. Patients and solipsism: the psychology of decision making for prostate cancer treatment. Urol Oncol. 2011 May-Jun; 29(3):233-4. Chamie K, Saigal CS, Litwin MS. PMID: 21714161.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    123. Outcomes after pediatric ureteral reimplantation: a population based analysis. J Urol. 2011 Jun; 185(6):2292-7. Nguyen HG, Chamie K, Nguyen KG, Durbin-Johnson B, Kurzrock EA. PMID: 21511291.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    124. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort. Urology. 2011 Jun; 77(6):1330-6. Palvolgyi R, Daskivich TJ, Chamie K, Kwan L, Litwin MS. PMID: 21492911.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    125. Comorbidity and competing risks for mortality in men with prostate cancer. Cancer. 2011 Oct 15; 117(20):4642-50. Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS. PMID: 21480201.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    126. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors. Cancer. 2011 Sep 15; 117(18):4219-30. Chamie K, Kurzrock EA, Evans CP, Litwin MS, Koppie TM, Wootton-Gorges SL, Boone JM, Lara PN, Devere White RW. PMID: 21412759.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    127. Physician assessment of pretreatment functional status: a process-outcomes link. J Urol. 2011 Apr; 185(4):1229-33. Chamie K, Sadetsky N, Litwin MS. PMID: 21334026.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    128. Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer. 2011 May 15; 117(10):2058-66. Daskivich TJ, Chamie K, Kwan L, Labo J, Palvolgyi R, Dash A, Greenfield S, Litwin MS. PMID: 21523717.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    129. Prostate cancer: the challenge of comparing open and laparoscopic surgery. Nat Rev Urol. 2010 Mar; 7(3):121-2. Chamie K, Litwin MS. PMID: 20220751.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    130. Contemporary open ureteral reimplantation without morphine: assessment of pain and outcomes. J Urol. 2009 Sep; 182(3):1147-51. Chamie K, Chi A, Hu B, Keegan KA, Kurzrock EA. PMID: 19625056.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    131. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res. 2009 Feb 01; 15(3):788-96. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM. PMID: 19188148; PMCID: PMC2666194.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    132. Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma. J Urol. 2009 Mar; 181(3):1013-8; discussion 1018-9. Hellenthal NJ, Chamie K, Ramirez ML, deVere White RW. PMID: 19150554.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    133. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008 Nov 01; 113(9):2464-70. Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM. PMID: 18666213.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    134. The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. Am J Transplant. 2008 Dec; 8(12):2668-73. Chamie K, Ghosh PM, Koppie TM, Romero V, Troppmann C, deVere White RW. PMID: 18853950; PMCID: PMC4376320.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    135. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int. 2008 Aug; 102(3):284-90. Chamie K, Hu B, Devere White RW, Ellison LM. PMID: 18410437.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    136. Short stay pyeloplasty: variables affecting pain and length of stay. J Urol. 2008 Apr; 179(4):1549-52. Chamie K, Tanaka ST, Hu B, Kurzrock EA. PMID: 18295264.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    137. Cost-benefit and outcome analysis: effect of prostate biopsy undergrading. Urology. 2007 Jun; 69(6):1152-6. Cambio AJ, Ellison LM, Chamie K, deVere White RW, Evans CP. PMID: 17572205.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    138. Benign retroperitoneal schwannoma: a case series and review of the literature. Urology. 2003 Dec; 62(6):993-7. Daneshmand S, Youssefzadeh D, Chamie K, Boswell W, Wu N, Stein JP, Boyd S, Skinner DG. PMID: 14665342.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    139. Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol. 2001 Oct; 27(2):133-44. Perfetti R, Hui H, Chamie K, Binder S, Seibert M, McLenithan J, Silver K, Walston JD. PMID: 11564599.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Karim's Networks
    Concepts (398)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (65)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-2-gbbe5f151 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California